<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:department>Molecular and Biochemical Parasitology</gtr:department><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6A0B12A7-D6E8-4F76-8B20-1B83FA1694B0"><gtr:id>6A0B12A7-D6E8-4F76-8B20-1B83FA1694B0</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:otherNames>Gerrard</gtr:otherNames><gtr:surname>Bray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400173"><gtr:id>C532863F-896B-4910-9419-6C551EC75323</gtr:id><gtr:title>Transport of Organic Cations in Plasmodium falciparum</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400173</gtr:grantReference><gtr:abstractText>Plasmodium falciparum malaria causes immense public health and economic problems in most developing countries. During its complex life cycle, the malaria parasite invades the red blood cells of its human host and undergoes a phase of rapid growth and division that produces most of the clinical symptoms of the disease. Living inside the red cells of its host helps the parasite to avoid the host immune system but this protection comes at a price: the metabolically active parasite must obtain all of its nutrients from within a relatively inactive host cell. Hence, the parasite causes an increase in the permeability of the host cell to a variety of solutes, including a positively charged molecule that is subsequently taken up by the intracellular parasite and used to synthesize its cell membranes. We are particularly interested in the mechanism by which this molecule is taken up by the intracellular parasite because the molecule is essential to its survival. If we can identify the protein that is responsible we will be able to design new drugs that knock it out and kill the parasite. Because it is different to its human counterparts we can also make use of this transport protein to deliver toxic drugs just to the intracellular parasite and kill it without harming human cells. We propose to use modern molecular and cell imaging techniques to identify and characterize this protein. This information will advance our understanding of the complex interaction of the intracellular parasite with its host red cell. As outlined above, transport pathways afford great opportunities for the development of new drugs to combat malaria, both as drug targets in their own right and as routes for the delivery of drugs to kill the intracellular parasite.</gtr:abstractText><gtr:technicalSummary>I have identified a novel plasma membrane transporter used by intracellular P.falciparum parasites to obtain choline and other organic cations from the environment. The transporter also serves as an access route for positively charged antimalarial drugs into the parasite cytoplasm. Choline and other organic cations enter the cytoplsm of the infected erythrocyte via well characterized new permability pathways (NPP). The new transporter is located in the parasite plasma membrane (PPM) and is kinetically and pharmacologically distinct from the NPP. The transporter delivers essential organic cations such as choline to the parasite cytoplasm, answering the longstanding question of how these compounds find their way into the intracellular parasite after gaining access to the red cell cytoplasm via the NPP. I propose to conduct a physiological, biochemical and molecular investigation of this novel parasite plasma membrane organic cation transporter. Functional characterization of this pathway at the protein level will advance our understanding of the fundamental biology of interactions operating at the host-parasite interaface and will contribute to the rational development of novel and highly selective antimalarial agents.</gtr:technicalSummary><gtr:fund><gtr:end>2010-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>325942</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Folate Transport in Plasmodium falciparum (by CAB International) (occasion: Molecular Approaches to Malaria, Lorne Australia)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>885C7D60-2859-4694-8136-4567B0ACF473</gtr:id><gtr:impact>Molecular Approaches to Malaria Conference. February 3-7, 2008. Invited lecture given by Dr Enrique Salcedo describing the folate transporter work that was funded by this MRC project. Abstract published in The International journal of Parasitology, January 2008 PMID: 18335576

Covered in a conference review, published in Trends in Parasitology, December 2008 PMID: 18938106.</gtr:impact><gtr:outcomeId>BAFF07A8D5B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Areas of interest: functional characterisation of membrane transporters of malaria parasites</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>4C010646-5E9D-43E4-B1BB-D84E4BE0AB73</gtr:id><gtr:impact>Information for the lay audience about the activities of my research group, including detailed descriptions of MRC funded research findings. Updated on an annual basis.

None</gtr:impact><gtr:outcomeId>8F7CA961EA9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>36000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DDACC9FE-A8D7-435E-8F51-462D3A973D7C</gtr:id><gtr:outcomeId>BA646484A670</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>121135</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EC FP6 Integrated Project</gtr:description><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>8C942B75-5012-4458-BC41-66DBF5CA8117</gtr:id><gtr:outcomeId>19E1DD9A4970</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Dr Patrick Bray invited membership of the Grants committee for the British Society for Chemotherapy</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>7C921F46-923A-4914-9113-038D58E74DEF</gtr:id><gtr:impact>Specialist advisor in the area of chemotherapy of parasitic diseases. Grants committee oversees approximately 20 applications for various overseas fellowships, PhD studentships and small project grants per year.</gtr:impact><gtr:outcomeId>82A1A5C33AC</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1BF5FB1A-1341-4AF4-81C1-4DAEDA69F383</gtr:id><gtr:title>A yeast expression system for functional and pharmacological studies of the malaria parasite Ca&amp;sup2;?/H? antiporter.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d436bdab223cade1091ca9ed24b61485"><gtr:id>d436bdab223cade1091ca9ed24b61485</gtr:id><gtr:otherNames>Salcedo-Sora JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_540e13ae13af6989e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D95CB97-BB54-44BC-92E1-B2D30193583D</gtr:id><gtr:title>The molecular basis of folate salvage in Plasmodium falciparum: characterization of two folate transporters.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d436bdab223cade1091ca9ed24b61485"><gtr:id>d436bdab223cade1091ca9ed24b61485</gtr:id><gtr:otherNames>Salcedo-Sora JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_540e13ae13acde69e</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400173</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>